A systematic review of the effect of semaglutide on Lean Mass: insights from clinical trials

CONCLUSION: Semaglutide displays potential for weight loss primarily through fat mass reduction. However, concerns arise from notable reductions in lean mass, especially in trials with larger number of patients.PMID:38629387 | DOI:10.1080/14656566.2024.2343092

Source: Expert Opinion on Pharmacotherapy - April 17, 2024 Category: Drugs & Pharmacology Authors: Alexia Bikou Foteini Dermiki-Gkana Michail Penteris Theodoros K Constantinides Christos Kontogiorgis Source Type: research